Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • English-only
      • News Releases Overview

      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
      • Multimedia Gallery Overview

      • Trending Topics

      • All Trending Topics
  • Business & Money
      • Auto & Transportation

      • All Automotive & Transportation
      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • Auto & Transportation Overview

      • View All Auto & Transportation

      • Business Technology

      • All Business Technology
      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • Business Technology Overview

      • View All Business Technology

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Financial Services & Investing

      • All Financial Services & Investing
      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • Financial Services & Investing Overview

      • View All Financial Services & Investing

      • General Business

      • All General Business
      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • General Business Overview

      • View All General Business

  • Science & Tech
      • Consumer Technology

      • All Consumer Technology
      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • Consumer Technology Overview

      • View All Consumer Technology

      • Energy & Natural Resources

      • All Energy
      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • Energy & Natural Resources Overview

      • View All Energy & Natural Resources

      • Environ­ment

      • All Environ­ment
      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • Environ­ment Overview

      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • All Heavy Industry & Manufacturing
      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • Heavy Industry & Manufacturing Overview

      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • All Telecomm­unications
      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • Telecomm­unications Overview

      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • All Consumer Products & Retail
      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • Consumer Products & Retail Overview

      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Health

      • All Health
      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • Health Overview

      • View All Health

      • Sports

      • All Sports
      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • Sports Overview

      • View All Sports

      • Travel

      • All Travel
      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • Travel Overview

      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • All Policy & Public Interest
      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • Policy & Public Interest Overview

      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • All People & Culture
      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • People & Culture Overview

      • View All People & Culture

      • In-Language News

      • Arabic
      • español
      • português
      • Česko
      • Danmark
      • Deutschland
      • España
      • France
      • Italia
      • Nederland
      • Norge
      • Polska
      • Portugal
      • Россия
      • Slovensko
      • Suomi
      • Sverige
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Report Results
  • Amplify Content
  • All Products
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • ALL CONTACT INFO
    • Contact Us

      888-776-0942
      from 8 AM - 10 PM ET

  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • News in Focus
    • Browse All News
    • Multimedia Gallery
    • Trending Topics
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Report Results
  • Amplify Content
  • All Products
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS

Infinitus Launches AI-First, Human-Backed Hub Solution to Replace Specialty Pharma's Legacy Call-Center Infrastructure

Infinitus Systems, Inc.

News provided by

Infinitus Systems, Inc.

Jul 30, 2026, 06:03 ET

Share this article

Share toX

Share this article

Share toX

AI absorbs routine volume and human experts own every judgment call – cutting administrative cost up to 30% while ensuring patients get expert support exactly when it matters most

SAN FRANCISCO, July 30, 2026 /PRNewswire/ -- Today, Infinitus Systems, Inc., healthcare's agentic communications partner powering more than 350 million healthcare interactions, announced the launch of its AI-first hub solution, an end-to-end model built to replace the industry's outdated, manual, and high-cost "call-center" hub infrastructure.

Unlike legacy hubs – or approaches that introduce AI into isolated workflows – Infinitus' AI-first hub solution was designed to unite AI agents and human expertise across the entire patient journey. AI agents handle the routine 24/7 – enrollment, status updates, general inquiries, and more. Human experts engage where judgment or empathy is needed: exceptions, escalations, and anything clinical or ambiguous. Agents provide a warm hand-off with context to human experts so that they can be most effective.

Importantly, the model scales with minimal needs for seasonal headcount, as AI agents handle most of the volume. During a recent annual re-verification cycle, for example, Infinitus absorbed a 144% patient volume surge with zero additional full-time employees hired – proof that AI, not headcount, is what carries peak demand.

This launch comes at a critical time: as specialty therapies grow more complex, pharmaceutical manufacturers are actively seeking alternatives to legacy patient-support models that improve access, accelerate therapy initiation, and give better visibility into the patient journey end to end, without sacrificing the human judgment patients depend on. For manufacturers, the stakes go beyond operations. A patient's first real interaction with a brand is often the hub experience itself – and a slow, confusing, or impersonal one can undo months of marketing investment before treatment even begins.

"Up to 40% of patients prescribed these life-changing specialty therapies drop off before ever starting treatment, often because slow, manual hub processes compound the cost and prior-auth delays that are already working against them," said Ankit Jain, CEO and co-founder of Infinitus. "We built our AI-first hub solution to eliminate that bottleneck – but speed only matters if it's trustworthy. That's why every case that involves clinical nuance or a judgment call is routed to one of our trained, certified human experts automatically. Patients get their therapies faster, and a person is always the one making the calls that matter."

Coinciding with this launch, a major pharmaceutical manufacturer's leading brand's patient support program has selected Infinitus to manage the end-to-end patient journey through its AI-first, human-backed approach designed to improve scalability, cost-efficiency, and patient experience, without compromising oversight.

The AI-first hub solution can reduce administrative costs by 30% while significantly accelerating patients' time to treatment. Built on hundreds of millions of healthcare interactions, Infinitus enables patient support programs to deploy AI and go live significantly faster than platforms that weren't purpose-built for healthcare.

Here's how it works:

  • Digital Intake and Form Cleanup: Processes digital prescription forms (EACs) directly into Salesforce, using AI agents to automatically call provider offices to recover missing information.
  • Benefit Verification and Prior Authorization Tracking: Instantly runs insurance checks to determine copay assistance eligibility while continuously tracking prior authorization status.
  • 24/7 Patient Support and Adherence: Provides after-hours assistance using pre-approved clinical content, coordinates medication delivery with specialty pharmacies, and provides ongoing adherence reminders. 
  • Smart Handoffs: Built-in clinical awareness allows the Infinitus platform to instantly route complex inquiries to human case managers, while summarizing after-hours conversations so teams can take over the next morning. 
  • Same-Day Insights: Leverages Infinitus Lens to monitor all human and AI interactions in near-real-time, delivering actionable analytics the same day instead of the standard monthly wait of legacy hubs.

Infinitus has been automating patient support workflows since 2019, and is used by eight of the 10 largest pharmaceutical manufacturers. With this launch, Infinitus is helping manufacturers move the entire patient journey from awareness through adherence onto one AI-first, human-backed solution, rather than layering AI onto the same fragmented hub infrastructure they've always had. 

The launch follows the recent releases of Clinical Escalations, a risk detection system that ensures healthcare AI agents appropriately triage patients, regardless of the stated intent of a healthcare interaction and Infinitus Studio, the first no-code AI agent builder for healthcare.

About Infinitus
Infinitus is healthcare's agentic AI communications partner, enabling intelligent care that reduces patient anxiety, increases speed to treatment, and enables teams to scale impact without stretching resources. Infinitus' system combines industry-leading safety guardrails with the largest dynamic knowledge graph built on millions of real-world interactions. The company has raised over $100M from investors including Google Ventures, Kleiner Perkins, Andreessen Horowitz, and Coatue. Infinitus was recently named to Fast Company's World's Most Innovative Companies and is a trusted solutions partner to 44% of Fortune 50 healthcare companies. Learn more at https://www.infinitus.ai/ 

SOURCE Infinitus Systems, Inc.

21%

more press release views with 
Request a Demo

Modal title

Also from this source

Infinitus Introduces Clinical Escalations, Bringing Real-Time Clinical Risk Detection to Healthcare AI Agent Conversations

Infinitus Introduces Clinical Escalations, Bringing Real-Time Clinical Risk Detection to Healthcare AI Agent Conversations

Today, Infinitus Systems, Inc., healthcare's leading agentic communications partner powering more than 100 million minutes of conversations,...

Infinitus Introduces The First Solution to Evaluate Every Healthcare Interaction Led by AI or Humans

Infinitus Introduces The First Solution to Evaluate Every Healthcare Interaction Led by AI or Humans

Today, Infinitus Systems, Inc., healthcare's leading agentic communications partner powering more than 100 million minutes of conversations,...

More Releases From This Source

Explore

Health Care & Hospitals

Health Care & Hospitals

Computer & Electronics

Computer & Electronics

Artificial Intelligence

Artificial Intelligence

The Latest Artificial Intelligence News

The Latest Artificial Intelligence News

News Releases in Similar Topics

Contact PR Newswire

  • Call PR Newswire at 888-776-0942
    from 8 AM - 9 PM ET
  • Chat with an Expert
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices

Products

  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Report Results
  • Amplify Content

About

  • About PR Newswire
  • About Cision
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Italy
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • Vietnam

My Services

  • All New Releases
  • Platform Login
  • Data Privacy

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Platform Login
  • ProfNet
Call PR Newswire at
888-776-0942
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookies
Copyright © 2026 Cision US Inc.